Bellevue Group AG

Q2 2022 13F Detailed Holdings

Location
Kuesnacht, Switzerland
Holdings as of
6/30/2022
Value ($000)
$7,074,165
Num holdings
214
Date filed
8/11/2022
Form type
13F-HR
Prev filing
5/13/2022
Next filing
11/14/2022
Note
Holdings broken out by “other managers” reported in original SEC filing, see here for holdings aggregated across other managers
Sym Issuer Name Cl CUSIP Value ($000) % Shares Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 BB Biotech AG 28-06964
2 Bellevue Asset Management AG 28-16892
3 Bellevue Asset Management (UK) Ltd. 28-20408